SCHEMBL3661291

SCHEMBL3661291

N#Cc1cc(Br)c(-c2ccccc2Cl)nc1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
L3MBTL1 Q9Y468 3/20 0.45
LMNA P02545 1/20 0.45
HPGD P15428 1/20 0.45
KMT2A Q03164 1/20 0.45
CNR1 P21554 8/20 0.44
CNR2 P34972 8/20 0.44
AR P10275 1/20 0.40
GAA P10253 1/20 0.40
MYC P01106 1/20 0.39
WDR5 P61964 1/20 0.39
ADORA2A P29274 1/20 0.39
ADORA1 P30542 1/20 0.39
ALDH1A1 P00352 4/20 0.39
TDP1 Q9NUW8 1/20 0.39
LRRK2 Q5S007 1/20 0.38
KDM4E B2RXH2 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3479342 0.78 CNR1 (0.70) NPSR1CYP1A2CYP2C9CYP2C19CNR1
SCHEMBL23234817 0.74 NPSR1 (0.54) NPSR1CYP1A2CYP2C9CYP2C19L3MBTL1
SCHEMBL21530997 0.74 KHK (0.49) NPSR1CYP1A2CYP2C9CYP2C19L3MBTL1
SCHEMBL31745211 0.74 KHK (0.49) NPSR1CYP1A2CYP2C9CYP2C19L3MBTL1
SCHEMBL8778840 0.73 KHK (0.48) NPSR1CYP1A2CYP2C9CYP2C19GAA
SCHEMBL3291080 0.71 DPP4 (0.53) L3MBTL1CNR1CNR2ARGAA
SCHEMBL30251471 0.71 HSP90AA1 (0.44) KMT2ACNR1CNR2GAAMYC
SCHEMBL29256315 0.71 HSP90AA1 (0.44) KMT2ACNR1CNR2GAAMYC
SCHEMBL23234736 0.71 NPSR1 (0.47) NPSR1CYP1A2CYP2C9CYP2C19L3MBTL1
SCHEMBL6714815 0.70 L3MBTL1 (0.64) L3MBTL1LMNAHPGDKMT2ACNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2139333-A1 SUBSTITUTED PYRIDO[3,2-E][1,2,4]TRIAZOLO[4,3-C]PYRIMIDINE DERIVATIVES AS CANNABINOID-1 RECEPTOR MODULATORS Merck & Co., Inc. (US) 2010-01-06 EP disclosed
WO-2008118414-A1 SUBSTITUTED PYRIDO[3,2-E][1,2,4]TRIAZOLO[4,3-C]PYRIMIDINE DERIVATIVES AS CANNABINOID-1 RECEPTOR MODULATORS MERCK & CO., INC. (US) 2008-10-02 WO disclosed